Sarah Lewis
Puminan Punthasee
Roman Hillebrand
Kasi Ruddraraju
Andrea Cummings
Kent Gates
Protein tyrosine phosphatases (PTPs) are a class of enzymes that play important roles in the regulation of many mammalian signaling pathways. A number of different PTPs are potential medicinal targets for the treatment of cancer, type 2 diabetes, and autoimmune diseases. The active sites of all PTPs are highly homologous and it has proven challenging to develop selective inhibitors against individual members of this enzyme family. Here we describe the design, synthesis, and characterization of exo-affinity labeling agents for the inactivation of PTPs. These agents combine phosphotyrosine isosteres with biocompatible electrophiles such as thioester groups to react with residues outside the active site. This approach has the potential to exploit differences outside the active sites of the PTPs to yield selective and potent inactivators.
Ask a Question
Get involved to find out more about this Presentation.
All Comments
Log In to participate in the discussion
Discover more research and events on morressier.com